Cancer Research Center of Hawaii, Honolulu, HI 96813, USA.
Eur J Clin Nutr. 2010 Jun;64(6):652-4. doi: 10.1038/ejcn.2010.36. Epub 2010 Mar 10.
Although some evidence suggests a protective role of vitamin D against breast cancer, epidemiological findings are inconsistent. The current study investigated the relation of serum 25-hydroxyvitamin D (25(OH)D) levels with mammographic density. Baseline serum samples from 182 premenopausal women including 67 Caucasians and 74 Asians from a nutritional trial were analyzed for 25(OH)D. Mammographic density was assessed using a computer-assisted method. Serum 25(OH)D was not associated with mammographic density after adjustment for confounders (body mass index (BMI), age at mammogram, Asian ethnicity, age at first birth, parity and age at menarche). 25(OH)D levels were significantly lower in Asians than in Caucasians, but no significant ethnic differences in mammographic density were observed after adjusting for BMI. Although the current results indicate that serum 25(OH)D levels were not associated with mammographic density among premenopausal women, a possible protective effect of vitamin D against breast cancer may be mediated through other pathways.
虽然有一些证据表明维生素 D 对预防乳腺癌具有保护作用,但流行病学研究结果并不一致。本研究调查了血清 25-羟维生素 D(25(OH)D)水平与乳腺密度的关系。对营养试验中 182 名绝经前妇女(包括 67 名白人和 74 名亚洲人)的基线血清样本进行了 25(OH)D 分析。使用计算机辅助方法评估乳腺密度。调整混杂因素(体重指数(BMI)、乳腺 X 光片拍摄年龄、亚洲种族、初产年龄、产次和初潮年龄)后,血清 25(OH)D 与乳腺密度无关。亚洲人的 25(OH)D 水平明显低于白种人,但调整 BMI 后,乳腺密度无明显的种族差异。尽管目前的结果表明,绝经前妇女的血清 25(OH)D 水平与乳腺密度无关,但维生素 D 对乳腺癌的可能保护作用可能通过其他途径介导。